Pulmonary Hypertension

Pulmonary hypertension is a fatal disease that attacks many people at the productive age.Pulmonary hypertension incidence in women is two and a half times more than men.Pulmonary hypertension derived or associated with genetic factors .Estimated one to two million people per year diagnosed pulmonary hypertension.In Indonesia and Asia Pacific, people with pulmonary hypertension under-diagnosed  and less treatment due to lack of patient awareness of pulmonary hypertension.

More over many sufferers are not aware that he had pulmonary hypertension.If pulmonary hypertension and left untreated, life expectancy is usually less than three years.Majority a sufferer pulmonary hypertension is the productive age between 20 to 40 years.

As technology advances, treatment with inhaled claimed as the only treatment that works selectively in the lungs that can increase life expectancy and eliminate the symptoms and side effects of pulmonary hypertension.Iloprost which is a type of inhaled drug for pulmonary hypertension that has been ratified.It works almost the same as prostaglandins, which opens blood vessels in the lungs to improve blood flow to vital organs, so that breathing becomes more relieved because more oxygen to flow to the heart and other organs.

The References :
1. www.katrinatribute.info
2. www.hanyawanita.com